Jul 1, 2024, 09:12
Agenus – CTEP has announced the availability of botensilimab for clinical studies
Agenus shared on LinkedIn:
“The National Cancer Institute (NCI)‘s Cancer Therapy Evaluation Program (CTEP) has announced the availability of our therapy, botensilimab, for clinical studies. ”.
Read further.
Source: Agenus/LinkedIn